Tilray Brands forms German pharmacy distribution alliance with gesund leben and Alliance Healthcare Deutschland

Reuters03-12 19:00
Tilray Brands forms German pharmacy distribution alliance with gesund leben and <a href="https://laohu8.com/S/MIJ.SI">Alliance Healthcare</a> Deutschland

Tilray Pharma said Tilray Medical, CC Pharma, and 14U Pharma will form a strategic alliance with the “gesund leben” cooperation, operated by Alliance Healthcare Deutschland, to expand pharmacy access in Germany. Effective April 1, 2026, the parties plan to supply “gesund leben” partner pharmacies with prescription medicines, parallel-import discounted medicines, and Tilray Medical’s medical cannabis products. Alliance Healthcare Deutschland operates 27 logistics centers and supplies more than 10,000 pharmacies daily. The “gesund leben” cooperation includes about 3,600 member pharmacies across Germany.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603120700OMX_____CNEWS_EN_GNW9670277_en) on March 12, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment